Editorial Superbacterias dependientes de antibióticos

References

Chakrakodi V. Some bacteria loves antibiotics. Disponible en: http://varuncnmicro.blogspot.com/2013/02/some-bacteria-loves-antibiotic.html. Acceso: 24/04/2018.

Gholizadeh Y, Prevost M, Bambeke F, Casadewall B, Tulkens P, Courvalin P. 2001. Sequencing of the ddl gene and modeling of the mutated D-alanine:D-alanine ligase in glycopeptide-dependent strains of Enterococcus faecium. Protein Sci. 2001;10:836-844.

Dever L, Smith S, Handwerger S, Eng R. Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol. 1995;33(10):2770-2773.

Fraimow H, Jungkind D, Lander D, Delso D, Dean J. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med. 1994;121:22-26.

Van Bambeke F, Chauvel M, Reynolds P, Fraimow H, Courvalin P. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob. Agents Chemother. 1999;43:41-47.

Farrag N, Eltringham I, Liddy H. Vancomycin-dependent Enterococcus faecalis. Lancet 1996;348(9041):1581-1582.

Tambyah P, Marx J, Maki D. Nosocomial infection with vancomycin-dependent enterococci. Emerg. Infec Dis. 2004;10(7):1277-1281.

Rosato A, Pierre J, Billot-Klein D, Buu-Hoi A, Gutmann L. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother. 1995;39:830–833.

Moubareck C, Meziane-Cherif D, Courvalin P, Perichon B. VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth. Antimicrob Agents Chemother. 2009;53:3657-3663.

Meziane-Cherif D, Saul F, Moubareck C, Weber P, Haouz A, Courvalin P. et al. Molecular basis of vancomycin dependence in VanA-type Staphylococcus aureus VRSA-9. J Bacteriol. 2010;192(20): 5465-5471.

Lee J, Chung E, Ko K. Transition of colistin dependence into colistin resistance in Acinetobacter baumannii. Sci Rep 2017;7:1421612.

Hawley J, Murray C, Jorgensen J. Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Antimicrob Agents Chemother.2007;51:4529-4530.

García-Quintanilla M, Carretero-Ledesma M, Moreno-Martínez P, Martín-Peña R, Pachon J, McConnell M. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin, and vancomycin in Acinetobacter baumannii. Int J Antimicrob Agents. 2015;46:696-702.

Hong Y, Lee J, Wi Y, Ko K. High rate of colistin dependence in Acinetobacter baumannii. J. Antimicrob Chemother. 2016;71:2346-2348.

Zhong M, Zhang X, Wang Y, Zhang C, Chen G, Hu P. et al. An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2010;14(1):40–44.

Woodford N, Johnson A, Morrison D, Hastings J, Elliot T, Worthington A. et al. Vancomycin-dependent enterococci in the United Kingdom. J Antimicrob Chemother. 1994.33:1066 (Letter).

Kuo S, Huang S, Lee C. Vancomycin-dependent Enterococcus faecium can easily be obscured. J Microbiol Immunol Infect. 2017;50(6): 926-927.

Chou C, Lee N, Lee N, Chang C, Lee C, Ko W. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan. J Microbiol Immunol Infect.2012;45: 221-227.

Published
2018-06-08
How to Cite
1.
Castellano-Gonzalez MJ. Editorial Superbacterias dependientes de antibióticos. Kasmera [Internet]. 2018Jun.8 [cited 2025Apr.10];46(1):5-. Available from: https://mail.produccioncientificaluz.org/index.php/kasmera/article/view/24647
Issue
Vol. 46 No. 1 (2018)
Section
Editorial

Copyright (c) 2019 Maribel Josefina Castellano-Gonzalez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.

The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.

Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.